Written informed consent is an ethical requirement before admitting patients to clinical drug trials. Matching cases by age/sex (A) is not standard practice; subjects should be representative rather than random samples (B); patients are typically blinded to treatment allocation (D); admitting clinicians should not know allocation to avoid bias (E).